Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| GnRH signaling pathway | R-HSA-168638 | map04912 | methylprednisolone | 6741 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | clomipramine | 2801 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | clomipramine | 2801 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | clomipramine | 2801 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | clomipramine | 2801 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | clomipramine | 2801 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | clomipramine | 2801 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | clomipramine | 2801 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | clomipramine | 2801 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | clomipramine | 2801 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | clomipramine | 2801 | drug-path |
| Asthma | R-HSA-444620 | map05310 | clomipramine | 2801 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | clomipramine | 2801 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | clomipramine | 2801 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | clomipramine | 2801 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | clomipramine | 2801 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | clomipramine | 2801 | drug-path |
| Glioma | Q9NZM4 | map05214 | clomipramine | 2801 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | clomipramine | 2801 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | clomipramine | 2801 | drug-path |